prof. dr. B. (Bob) Wilffert

Head of Department PharmacoTherapy, -Epidemiology and -Economics

Research

Postal address:
A Deusinglaan1
Gebouw 3214, ruimte 0466
9713 AV
Groningen
Netherlands
Phone: +31 50 363 7576
  1. 2020
  2. Fedorenko, O. Y., Paderina, D. Z., Loonen, A. J. M., Pozhidaev, I., Boiko, A. S., Kornetova, E. G., ... Ivanova, S. A. (2020). Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human Psychopharmacology, [2737]. https://doi.org/10.1002/hup.2737
  3. Lunenburg, C. A. T. C., van der Wouden, C. H., Nijenhuis, M., Crommentuijn-van Rhenen, M. H., de Boer-Veger, N. J., Buunk, A. M., ... Guchelaar, H-J. (2020). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines. EJHG, 28, 508–517. https://doi.org/10.1038/s41431-019-0540-0
  4. Boiko, A. S., Ivanova, S. A., Pozhidaev, I. V., Freidin, M. B., Osmanova, D. Z., Fedorenko, O. Y., ... Loonen, A. J. M. (2020). Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors. The World Journal of Biological Psychiatry, 21(1), 72-77. https://doi.org/10.1080/15622975.2018.1548780
  5. Pozhidaev, I., Boiko, A. S., Loonen, A. J. M., Paderina, D. Z., Fedorenko, O. Y., Tenin, G., ... Ivanova, S. A. (2020). Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia. The Application of Clinical Genetics, 13, 97-105. https://doi.org/10.2147/TACG.S247174
  6. 2019
  7. Osmanova, D. Z., Freidin, M. B., Fedorenko, O. Y., Pozhidaev, I. V., Boiko, A. S., Vyalova, N. M., ... Ivanova, S. A. (2019). A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC MEDICAL GENETICS, 20(Suppl 1), 47. https://doi.org/10.1186/s12881-019-0773-3
  8. Pozhidaev, I., Osmanova, D., Fedorenko, O., Vyalova, N., Semke, A., Wilffert, B., ... Ivanova (Svetlana Ivanova), S. A. (2019). The study of dopamine receptor genes in patients with schizophrenia. European Neuropsychopharmacology, 29(Suppl. 1), S410-S411. https://doi.org/10.1016/j.euroneuro.2018.11.624
  9. Levchenko, A., Vyalova, N., Pozhidaev, I. V., Boiko, A. S., Osmanova, D. Z., Fedorenko, O. Y., ... Ivanova, S. A. (2019). No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia. Human Psychopharmacology, 34(1), [e2685]. https://doi.org/10.1002/hup.2685
  10. 2018
  11. Swen, J. J., Nijenhuis, M., van Rhenen, M., de Boer-Veger, N. J., Buunk, A-M., Houwink, E. J. F., ... Dutch Pharmacogenetics Working Group (DPWG) of the Royal Dutch Pharmacists Association (KNMP) (2018). Pharmacogenetic Information in Clinical Guidelines: The European Perspective. Clinical Pharmacology & Therapeutics, 103(5), 795-801. https://doi.org/10.1002/cpt.1049
  12. Toshchakova, V. A., Bakhtiari, Y., Kulikov, A. V., Gusev, S. I., Trofimova, M. V., Fedorenko, O. Y., ... Ivanova, S. A. (2018). Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders. Neuropsychobiology, 75(4), 200-210. https://doi.org/10.1159/000487484
  13. Ivanova, S. A., Alifirova, V. M., Pozhidaev, I. V., Freidin, M. B., Zhukova, I. A., Osmanova, D. Z., ... Loonen, A. J. M. (2018). Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia. Journal of pharmacy and pharmaceutical sciences, 21(1), 340-346. https://doi.org/10.18433/jpps29903
Previous 1 2 3 4 5 6 7 8 Next

ID: 218810